Medicare Enrolled
Dr. Yoon Min, M.D.
Rheumatology · Santa Clarita, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Min from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Min?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Min
Dr. Yoon Min is a rheumatology specialist in Santa Clarita, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Min performed 16,648 Medicare services across 2,439 unique beneficiaries.
Between the years covered by Open Payments, Dr. Min received a total of $25,812 from 52 pharmaceutical and/or device companies across 1086 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Min is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in CA
$25,812 industry payments
Medicare Practice Summary
Medicare Utilization ↗16,648
Medicare services
Top 19% in CA for rheumatology
2,439
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~876 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,240 | $19 | $30 |
| Joint lubricant injection (TriVisc) An injection of hyaluronan or a derivative into a joint space. The dose specified is 1 milligram. |
2,475 | $7 | $30 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,546 | $1 | $10 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
1,219 | $18 | $45 |
| Joint lubricant injection (Durolane) An injection of hyaluronan or its derivative, specifically Durolane, administered directly into a joint space. |
1,200 | $6 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
975 | $105 | $294 |
| Electrical stimulation therapy, per 15 minutes Application of electrical stimulation to the body with a therapist present. The service is billed for each 15-minute increment of treatment. |
912 | $10 | $50 |
| Neuromuscular re-education therapy, per 15 min A therapy procedure designed to re-educate the functional connection between the brain, nerves, and muscles. It is billed in 15-minute increments. |
684 | $24 | $75 |
| Cardiolipin antibody (tissue antibody) measurement | 520 | $25 | $100 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
351 | $72 | $301 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
300 | $0 | $2 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
258 | $11 | $30 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
258 | $1 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
243 | $118 | $347 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
227 | $66 | $150 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
210 | $8 | $9 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
204 | $11 | $60 |
| Dimenhydrinate injection, up to 50 mg An injection of dimenhydrinate containing up to 50 mg of the medication. |
201 | $6 | $20 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
191 | $51 | $150 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
175 | $13 | $40 |
| Measurement of dna antibody, single stranded | 175 | $12 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $70 | $236 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
139 | $12 | $45 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
129 | $13 | $85 |
| Rheumatoid factor level | 129 | $6 | $21 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
87 | $44 | $200 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
76 | $56 | $200 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
61 | $59 | $160 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $136 | $467 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
51 | $1 | $20 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
48 | $36 | $180 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
45 | $26 | $300 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
42 | $33 | $120 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
39 | $1 | $20 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $147 | $326 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
18 | $59 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.4% high complexity
61.6% medium
35.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,812
Total received (2018-2024)
Avg $3,687/year across 7 years
Top 15% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,086
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,534 (95.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,277 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,064
2023
$3,979
2022
$3,690
2021
$2,895
2020
$3,974
2019
$3,960
2018
$3,250
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$913
AstraZeneca Pharmaceuticals LP
$434
Janssen Biotech, Inc.
$415
Mallinckrodt Hospital Products Inc.
$321
Novartis Pharmaceuticals Corporation
$232
ANI Pharmaceuticals, Inc.
$221
GlaxoSmithKline, LLC.
$202
Alexion Pharmaceuticals, Inc.
$196
US Oncology Corporate, Inc.
$192
Lilly USA, LLC
$159
Radius Health, Inc.
$140
UCB, Inc.
$137
ABBVIE INC.
$110
Fresenius Kabi USA, LLC
$106
Fidia Pharma USA Inc.
$49
DePuy Synthes Sales Inc.
$43
Octapharma USA, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$30
Aurinia Pharma U.S., Inc.
$25
PFIZER INC.
$22
WERFEN USA LLC
$21
Teva Pharmaceuticals USA, Inc.
$19
Ultragenyx Pharmaceutical Inc.
$15
SOBI, INC
$15
SCILEX PHARMACEUTICALS INC.
$15
Top 3 companies account for 43.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$5,052
Horizon Therapeutics plc
$2,079
Janssen Biotech, Inc.
$1,541
Mallinckrodt Hospital Products Inc.
$1,418
AstraZeneca Pharmaceuticals LP
$1,268
Radius Health, Inc.
$1,192
Lilly USA, LLC
$1,146
GENZYME CORPORATION
$1,144
Novartis Pharmaceuticals Corporation
$1,034
GlaxoSmithKline, LLC.
$961
AbbVie, Inc.
$949
Alexion Pharmaceuticals, Inc.
$882
ABBVIE INC.
$776
AbbVie Inc.
$696
PFIZER INC.
$690
UCB, Inc.
$660
E.R. Squibb & Sons, L.L.C.
$642
Celgene Corporation
$489
Fresenius Kabi USA, LLC
$365
ANI Pharmaceuticals, Inc.
$364
Mallinckrodt Enterprises LLC
$238
Genentech USA, Inc.
$198
Mallinckrodt LLC
$192
US Oncology Corporate, Inc.
$192
Janssen Scientific Affairs, LLC
$162
DePuy Synthes Sales Inc.
$145
Horizon Pharma plc
$137
Bioventus LLC
$120
Collegium Pharmaceutical, Inc.
$103
MEDAC PHARMA, INC.
$88
MEDEXUS PHARMA, INC.
$82
Octapharma USA, Inc.
$79
Exeltis, USA Inc.
$76
Aurinia Pharma U.S., Inc.
$75
Fidia Pharma USA Inc.
$74
Sobi, Inc
$71
Ultragenyx Pharmaceutical Inc.
$59
Egalet US Inc
$44
Kiniksa Pharmaceuticals, Ltd.
$43
SANOFI-AVENTIS U.S. LLC
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
Flexion Therapeutics, Inc.
$28
Orthogenrx Inc.
$26
Daiichi Sankyo Inc.
$23
Zimmer Biomet Holdings, Inc.
$23
WERFEN USA LLC
$21
Teva Pharmaceuticals USA, Inc.
$19
Avanos Medical
$17
SOBI, INC
$15
SCILEX PHARMACEUTICALS INC.
$15
Zyla Life Sciences
$15
BOSTON SCIENTIFIC CORPORATION
$11
Top 3 companies account for 33.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ARYMO ER · Actemra · Arcalyst · BENLYSTA · Belbuca · Bimzelx · COSENTYX · Cimzia · Crysvita · Durolane · EVENITY · EVUSHELD · Enbrel · Exogen · FORTEO · GENERAL PAIN MANAGEMENT · GenVisc 850 · HUMIRA · HYMOVIS · Humira · IDACIO · INFLECTRA · INJECTAFER · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · SYNVISC-ONE · Sports Medicine Product Portfolio · Strensiq · Supartz FX Sodium Hyaluronate · TALTZ · TAVNEOS · TREMFYA · TRIVISC SODIUM HYALURONATE · Truxima · Tymlos · XELJANZ · XTAMPZA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
43
Per 100K population
0.4
County median income
$87,760
Nearest hospital
HENRY MAYO NEWHALL HOSPITAL
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Min is a mixed practice specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Min experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Min performed 3,240 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Min receive payments from pharmaceutical companies?
Yes. Dr. Min received a total of $25,812 from 52 companies across 1,086 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Min's costs compare to other rheumatologists in Santa Clarita?
Dr. Min's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Min) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Santa Clarita
Browse rheumatologists in Santa Clarita ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in CA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in CA
Which CA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology